Robert J. Spiegel Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity
Robert J. Spiegel is Director of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 39,415 shares of CYCC, which is worth approximately $13,795. The most recent transaction as insider was on Jun 30, 2023, when has been sold 21,219 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
39.4K
0%
3M change
0%
12M change
Total Value Held
$13,795
Robert J. Spiegel Transaction History
Also insider at
RJS
Robert J. Spiegel
Director
Buffalo, NY